Health Care & Insurance

Fort Wayne firm to open health info to patients

February 16, 2011
J.K. Wall
With electronic medical record systems proliferating, there’s information galore about patients. But it’s not so easy for patients to get at it. Now Fort Wayne-based NoMoreClipboard has been charged to design ways to fix that problem.
More

Q&A

February 16, 2011
J.K. Wall
Harlon Wilson, president of Indianapolis-based Medical Animatics, says the uncertainty created by the recession and now health care reform have dried up most opportunities for his 3-D animation firm to win new business with health care clients. So he’s looking at new markets—such as the recent online learning work for Harrison College that led Medical Animatics to sell some of its assets to the for-profit university. And Wilson is still banking on persistent needs to educate patients to cause health care to bounce back.
More

St. Vincent CEO takes on new duties in Wisconsin

February 16, 2011
J.K. Wall
St. Vincent Health CEO Vince Caponi will take charge of three hospitals in Wisconsin that are also owned by St. Vincent’s parent organization, Ascension Health. He'll also keep his current job.
More

DeVry Inc. plans to open local nursing school

February 15, 2011
The for-profit school would lease 24,000 square feet at its Keystone Crossing campus and employ 55 people in its nursing program at an average wage of $28.85 an hour. DeVry is requesting property-tax abatement to offset investment costs.
More

Inspectors find Indiana tobacco sales to minors declining

February 14, 2011
Associated Press
A partnership called the Tobacco Retailer Inspection Program said Monday that sales of tobacco products to teen-agers occurred in less than 4 percent of more than 8,400 inspections.
More

St. Francis plans $23 million Carmel hospital

February 14, 2011
 IBJ Staff
Franciscan St. Francis Health plans to open a short-stay medical center in Carmel, creating 76 jobs by 2015, the health system announced Monday morning.
More

Repeated price cuts take glow off Endocyte IPORestricted Content

February 12, 2011
Greg Andrews
New investors got in for $6 a share—which is less than the average price paid by prior investors, a regulatory filing reveals.
More

Medicaid expansion could tax community health centersRestricted Content

February 12, 2011
J.K. Wall
The president of the Indiana Primary Health Care Association wants to double the number of federally qualified community health centers in Indiana in the next five years.
More

Diabetes boom sparks Roche expansion

February 12, 2011
J.K. Wall
Roche Diagnostics Corp. is expanding one of its Indianapolis manufacturing plants to keep up with growing sales of its leading brand of blood glucose monitors.
More

Lilly takeover provision to be voted on again

February 11, 2011
Scott Olson
The effort to remove an 80-percent approval threshold for takeover bids against the wishes of Lilly's board is on the agenda of the company's April 18 annual meeting.
More

Lilly names new head of cancer drug business

February 11, 2011
Associated Press
Eli Lilly and Co. on Friday named company insider Sue Mahony as president of its cancer drug business.
More

Health insurers expect hit from reform rule

February 9, 2011
Associated Press
Major health insurers, including WellPoint, say a provision that requires them to spend a certain percentage of the premiums they collect on care-related costs will eat into earnings this year.
More

Arcadia reports smaller loss on increased revenue

February 9, 2011
The Indianapolis-based health care company lost $2.3 million on revenue of $26.2 million in its third fiscal quarter.
More

Recent successes don't change Lilly's outlook

February 9, 2011
J.K. Wall
Eli Lilly and Co. can be credited with using acquisitions to unclog its product pipeline. It launched two drugs in the past 18 months, won market approval for a third and will likely get nods for two more drugs this year. Trouble is, they all have paltry sales prospects.
More

Daniels leads guvs' health-care revolt

February 9, 2011
J.K. Wall
Boy does Gov. Mitch Daniels have an ultimatum for President Obama: Wave off the health reform law or else I’ll do nothing to help while it wreaks havoc on Hoosier citizens.
More

Lilly collaboration with outside researchers yields first deal

February 8, 2011
Chris O'Malley
Eli Lilly and Co.'s PD2 project attracted 30,000 compounds from researchers in 26 countries. And Lilly scientist Alan Palkowitz said it's just the first of many such collaborations.
More

Struggling Lilly turns to antidepressant Cymbalta for lift

February 5, 2011
Greg Andrews
Cymbalta racked up $3.5 billion in sales last year, and some analysts say it may approach $5 billion before generic competition arrives in 2013.
More

Health insurance brokers set for shakeoutRestricted Content

February 5, 2011
J.K. Wall
Health insurance brokers, who match up employers with health insurance policies, are about to have a brighter light shone on the commissions they earn from insurers. The likely result: Commissions will fall or flatline and, eventually, fall away in favor of fee-based business models.
More

2010 compensation fell about 20 percent for top Lilly execs

February 4, 2011
J.K. Wall
Compensation for Eli Lilly and Co.’s top executives fell last year due to a change to its stock award program and as the company struggled to bring new medicines to market.
More

Indiana Farm Bureau unveiling ads during Super Bowl

February 4, 2011
Scott Olson
The insurer's new campaign, developed by local advertising firm Young & Laramore, focuses on real-life situations amid a crowded field of competitors.
More

Endocyte again changes terms of public offering

February 4, 2011
 IBJ Staff and Bloomberg News
The West Lafayette-based biopharmaceutical company now is planning to offer at least 12.5 million shares, or 17 percent more than previously announced, but at a lower price of $6 each.
More

Baldwin & Lyons reports higher revenue, lower profit

February 3, 2011
Indianapolis-based insurer of car and truck fleets posts quarterly profit slightly lower than a year ago. Revenue, however, rose to $67.7 million, up from $60.8 million in 2009.
More

Lilly, Bristol-Myers halt enrollment in lung-cancer trial

February 2, 2011
J.K. Wall
Eli Lilly and Co. and Bristol-Myers Squibb Co. stopped enrolling new patients in a clinical trial of an experimental lung cancer drug over concerns about patients developing blood clots.
More

Potential competitor to Lilly drug shows promise in study

February 2, 2011
 IBJ Staff and Bloomberg News
Sanofi-Aventis's experimental diabetes drug lixisenatide, given to volunteer patients once a day, was at least as effective as Eli Lilly and Co. and Amylin Pharmaceuticals Inc.'s twice-daily medicine Byetta, a study found.
More

Judge's ruling raises uncertainty for health care execs

February 2, 2011
J.K. Wall
After a federal judge in Florida struck down the entire health reform law, investors shrugged. But the uncertainty for executives in health care companies increased.
More
Page  << 51 52 53 54 55 56 57 58 59 60 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT